A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells

Synthetic membranes used in Franz diffusion cells for topical formulation quality assessment should provide least resistance to drug diffusion. In this study, the diffusion rates of ibuprofen across thirteen membranes were determined using Franz diffusion cells. Correlation of the membrane thickness, pore size and MWCO with drug fluxes was also made. The drug diffusion results showed that the porous membranes were categorized into high-flux (8–18 mg/cm2/h) and low-flux (0.1–3 mg/cm2/h) membranes. The drug fluxes did not show strong correlations (r2 < 0.99) with membrane parameters. Synthetic membranes can give variable drug fluxes, thus investigators should be careful in choosing membrane for formulation quality assessment.

[1]  J. Zatz,et al.  Membrane-solvent-solute interaction in a model permeation system. , 1988, Journal of pharmaceutical sciences.

[2]  Michael Levin,et al.  Nonsterile Semisolid Dosage Forms‚ÄîScale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Release Testing and In Vivo Bioequivalence Documentation SUPAC-SS , 2001 .

[3]  J. Liaw,et al.  Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[4]  N. Twist,et al.  Influence of solvents on paraben permeation through idealized skin model membranes , 1986 .

[5]  J. Marty,et al.  Influence of three synthetic membranes on the release of caffeine from concentrated W/O emulsions. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Sugibayashi Kenji,et al.  Prediction of skin permeability of drugs. II. Development of composite membrane as a skin alternative , 1992 .

[7]  J. Hadgraft,et al.  The penetration of supersaturated solutions of piroxicam across silicone membranes and human skin in vitro , 1997 .

[8]  B. Bergenståhl,et al.  The effect of rheological behaviour of a topical anaesthetic formulation on the release and permeation rates of the active compound. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  W. Chern,et al.  Development and Validation of In Vitro Release Tests for Semisolid Dosage Forms—Case Study , 2003 .

[10]  Smith Ew,et al.  In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation. , 1992 .

[11]  J. Haigh,et al.  In vitro diffusion cell design and validation. II. Temperature, agitation and membrane effects on betamethasone 17-valerate permeation. , 1992, Acta pharmaceutica Nordica.

[12]  J. Hadgraft,et al.  ATR-FTIR spectroscopic investigations on the effect of solvents on the permeation of benzoic acid and salicylic acid through silicone membranes. , 2001, International journal of pharmaceutics.

[13]  V. Shah,et al.  Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. , 1999, Pharmaceutical development and technology.

[14]  A. Cheung,et al.  Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. , 1983, Kidney international.

[15]  S. Zorin,et al.  In vitro test of nicotine's permeability through human skin. Risk evaluation and safety aspects. , 1999, The Annals of occupational hygiene.

[16]  S. Santoyo,et al.  In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin. , 1996, Pharmaceutica acta Helvetiae.

[17]  V. Shah.  In vitro drug release measurement for topical glucocorticoid creams , 1993 .

[18]  R. Bronaugh,et al.  In vitro release of nitroglycerin from topical products by use of artificial membranes. , 1992, Journal of pharmaceutical sciences.

[19]  T. Franz.  The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. , 1978, Current problems in dermatology.

[20]  I. Kanfer,et al.  ‘The insertion cell’: A novel approach to monitor drug release from semi-solid dosage forms , 1996 .

[21]  G P Moss,et al.  Investigation of the mechanism of flux across human skin in vitro by quantitative structure-permeability relationships. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  G. K. Wong,et al.  DEVELOPMENT AND VALIDATION OF IN VITRO RELEASE TESTING METHODS FOR SEMISOLID FORMULATIONS , 1993 .

[23]  D. Friend,et al.  Transdermal delivery of levonorgestrel. IV: Evaluation of membranes. , 1989, Journal of Pharmacy and Science.

[24]  T. Franz.  Percutaneous absorption on the relevance of in vitro data. , 1975, The Journal of investigative dermatology.

[25]  Norman Weiner,et al.  Validation of a Flow-Through Diffusion Cell for Use in Transdermal Research , 1987, Pharmaceutical Research.

[26]  K. Sugibayashi,et al.  Prediction of skin permeability of drugs. I. Comparison with artificial membrane. , 1990, Chemical & pharmaceutical bulletin.

[27]  H. Maibach,et al.  Topical and Transdermal Drug Products , 2010 .

[28]  M. C. Bonferoni,et al.  A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels. , 1999, Pharmaceutical development and technology.

[29]  Vinod P. Shah,et al.  In Vitro Release of Hydrocortisone from Topical Preparations and Automated Procedure , 2004, Pharmaceutical Research.

[30]  Eric W. Smith,et al.  Effect of Concentration and Degree of Saturation of Topical Fluocinonide Formulations on In Vitro Membrane Transport and In Vivo Availability on Human Skin , 1999, Pharmaceutical Research.

[31]  V. Shah,et al.  Determination of in vitro drug release from hydrocortisone creams , 1989 .

[32]  Isadore Kanfer,et al.  Release of acyclovir from semi-solid dosage forms: A semi-automated procedure using a simple plexiglass flow-through cell , 1995 .

[33]  Cynthia K. Brown,et al.  FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms , 2008, AAPS PharmSciTech.

[34]  S. Gallagher,et al.  Effects of Membrane Type and Liquid/Liquid Phase Boundary on In Vitro Release of Ketoprofen from Gel Formulations , 2003, Journal of drug targeting.

[35]  Programmierbarer Thermoblock,et al.  From industry , 1991 .